Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.20 $16.47 Friday, 10th May 2024 VRDN stock ended at $13.90. This is 0.0719% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 5.32% from a day low at $13.34 to a day high of $14.05.
90 days $12.20 $21.42
52 weeks $10.93 $28.35

Historical Viridian Therapeutics, Inc. prices

Date Open High Low Close Volume
Mar 25, 2019 $46.65 $48.60 $43.95 $44.70 14 876
Mar 22, 2019 $51.30 $52.05 $45.00 $47.70 33 186
Mar 21, 2019 $52.20 $57.00 $51.00 $52.35 26 197
Mar 20, 2019 $50.10 $52.05 $46.65 $51.15 24 758
Mar 19, 2019 $43.50 $52.35 $42.91 $49.80 39 866
Mar 18, 2019 $42.00 $45.38 $41.52 $42.75 23 942
Mar 15, 2019 $41.25 $43.35 $40.35 $42.00 20 174
Mar 14, 2019 $41.85 $42.30 $39.15 $40.80 25 510
Mar 13, 2019 $38.55 $40.65 $38.55 $39.75 12 706
Mar 12, 2019 $36.90 $39.15 $36.75 $38.40 6 853
Mar 11, 2019 $35.25 $37.80 $34.68 $36.75 13 468
Mar 08, 2019 $35.55 $36.05 $34.20 $34.80 10 170
Mar 07, 2019 $36.00 $37.67 $34.65 $35.70 11 374
Mar 06, 2019 $38.85 $38.85 $35.85 $36.00 12 010
Mar 05, 2019 $39.15 $40.05 $38.40 $38.85 4 535
Mar 04, 2019 $40.80 $41.55 $38.85 $39.15 8 033
Mar 01, 2019 $42.15 $42.75 $40.20 $40.35 15 010
Feb 28, 2019 $44.40 $44.40 $41.40 $42.00 7 457
Feb 27, 2019 $44.55 $44.55 $43.50 $43.80 2 477
Feb 26, 2019 $44.55 $45.15 $42.75 $44.55 3 349
Feb 25, 2019 $43.80 $45.15 $43.80 $44.55 8 338
Feb 22, 2019 $43.80 $43.80 $39.00 $43.50 34 417
Feb 21, 2019 $42.75 $43.80 $42.75 $43.35 3 754
Feb 20, 2019 $43.20 $43.50 $42.75 $43.05 2 898
Feb 19, 2019 $44.10 $45.15 $42.75 $43.35 6 258
Click to get the best stock tips daily for free!

About Viridian Therapeutics, Inc.

Viridian Therapeutics. Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as ... VRDN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT